AMPIO PHARMACEUTICALS INC (AMPE)
US03209T3077 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -8.63M | -16.34M | -17.08M | -15.89M | -13.63M | |||
| Depreciation Amortization | 122.00K | 1.05M | 1.09M | 1.18M | 1.27M | |||
| Change In Working Capital | 71.00K | -2.97M | 2.58M | -1.44M | 1.36M | |||
| Other non cash items | -125.00K | -2.87M | -690.00K | 1.43M | -4.38M | |||
| OPERATING CASH FLOW | -8.56M | -21.13M | -14.09M | -14.73M | -15.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -100.00K | -60.00K | -20.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | 0.00 | -100.00K | -60.00K | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 98.00K | 0.00 | 33.25M | 26.98M | 16.02M | |||
| Other Financing Activity | -98.00K | -110.00K | -2.51M | -1.37M | -1.66M | |||
| FINANCING CASH FLOW | 0.00 | -110.00K | 30.73M | 25.61M | 14.35M | |||
| CHANGE IN CASH | -8.56M | -21.24M | 16.54M | 10.82M | -1.05M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.56M | -21.13M | -14.09M | -14.73M | -15.38M | |||
| Capital Expenditure | N/A | 0.00 | -100.00K | -60.00K | -20.00K | |||
| FREE CASH FLOW | -8.56M | -21.13M | -14.19M | -14.79M | -15.40M | |||
All data in USD